ArticleMolecular therapy. Nucleic acids2024

Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope.

Ángela Covo-Vergara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.